Biopharma / Medtech Reports

March 31, 2025

Procept Biorobotics: Expecting ~20% Medicare Rate Cut

•

John Leppard

BSX (US), PRCT (US)
March 28, 2025

INSP, NYXH, LIVN: Sleep Apnea Coverage Timeline

•

John Leppard

INSP (US), LIVN (US), NYXH (US)
March 21, 2025

EXAS, GH: Colorectal Cancer Coverage in Hand, Edits to Come?

•

John Leppard

EXAS (US), GH (US)
March 20, 2025

EW, ABT: Tricuspid Replacement Coverage Benign

•

John Leppard

ABT (US), EW (US)
March 12, 2025

Guardant Health (GH): Next Steps on Shield

•

John Leppard

GH (US)
March 5, 2025

Life Science Tools: Court Intervention & NIH’s New Management

•

John Leppard

A (US), AVTR (US), BRKR (US), ILMN (US), MTD (US), QGEN (US), TMO (US), WAT (US)
March 3, 2025

[DXCM, OMI, AHCO] Glucose Monitors in the Crosshairs?

•

John Leppard

ABT (US), DXCM (US), OMI (US)
February 19, 2025

Renal Denervation: Medicare Coverage at 10%-20% of TAM?

•

John Leppard

MDT (US), OTSKY (US)
February 8, 2025

Life Science Tools: NIH Indirect Cost Cut Risks

•

John Leppard

AVTR (US), BRKR (US), ILMN (US), QGEN (US), TMO (US), TXG (US), WAT (US)
February 6, 2025

[EXAS, GH, GRAL] Multi-Cancer Coverage: Take 2

•

John Leppard

EXAS (US), GH (US), GRAL (US)